Abstract
Serum and cerebrospinal fluid (CSF) levels of haloperidol were measured in 12 chronic neuroleptic-non-responsive schizophrenic patients after 1 month on 60 mg haloperidol daily and then again after 1 month on 120 mg haloperidol daily. Serum haloperidol and CSF haloperidol rose with increasing dose. Serum and CSF levels were significantly correlated. No clinical improvement was achieved despite the high serum and CSF drug levels.
This is a preview of subscription content, log in via an institution to check access.
References
Bjørndal N, Bjerre M, Gerlach J, Kristjansen P, Magelund G, Oestrich IH, Waehrens J (1980) High-dosage haloperidol therapy in chronic schizophrenic patients: A double-blind study of clinical response, side effects, serum haloperidol, and serum prolactin. Psychopharmacology 67:17–23
Forsman A, Ohman R (1976) Pharmacokinetic studies on haloperidol in man. Curr Ther Res Clin Exp 20:319–336
Forsman A Ohman R (1977) Studies on serum protein binding of haloperidol. Curr Ther Res Clin Exp 21:245–255
Garver DL, Dekirmenjian H, Davis JM, Casper R, Ericksen S (1977) Neuroleptic drug levels and therapeutic response: Preliminary observations with red blood cell-bound butaperazine. Am J Psychiatry 134:304–307
Lader SR (1980) A radioreceptor assay for neuroleptic drugs in plasma. J Immunoassay 1:57–75
May PRA, Van Putten T (1978) Plasma levels of chlorpromazine in schizophrenia. Arch Gen Psychiatry 35:1081–1087
Overall JE, Gorham DR (1962) The brief psychiatric rating scale. Psychol Rep 10:799–812
Rubin RT, Forsman A, Heykants J, Ohman R, Tower B, Michels M (1980) Serum Haloperidol determinations in psychiatric patients. Arch Gen Psychiatry 37:1069–1074
Smith RC, Crayton J, Dikermenjian H, Klass D, Davis JM (1979) Blood levels of neuroleptic drugs in nonresponding chronic schizophrenic patients. Arch Gen Psychiatry 36:579–584
Spitzer RL, Endicott J, Robins E (1975) Research diagnostic criteria. Blometrics Research, New York State Psychiatric Institute. New York
Tune LE (1980) Haloperidol drug level monitoring: Pharmacokinetic and methodologic considerations with special emphasis on radioreceptor assay techniques. In: Ayd F (ed) Haloperidol update: 1958–1960. Ayd Medical Communications, Baltimore, pp 220–230
Tune LE, Creese I, Depaulo JR, Slavney PR, Snyder SH (1980) Clinical state and serum neuroleptic levels measured by radioreceptor assay in schizophrenia. Am J Psychiatry 137:187–190
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rimón, R., Averbuch, I., Rozick, P. et al. Serum and CSF levels of haloperidol by radioimmunoassay and radioreceptor assay during high-dose therapy of resistant schizophrenic patients. Psychopharmacology 73, 197–199 (1981). https://doi.org/10.1007/BF00429218
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00429218